Therefore, reducing cholinergic neuronal activity by a decrease of IGF-I brain entry/activity can cause the aggravation of different neurodegenerative diseases such as Alzheimer’s, Schizophrenia or Parkinson’s diseases, or aging. This evidence concerns the gene IGF1 and Parkinson disease.